It is arguably the most researched regenerative peptide in preclinical literature, with hundreds of published studies documenting its effects on: Angiogenesis (new blood vessel formation) Tendon-to-bone healing Nitric oxide pathway modulation Gastric mucosal protection Neurological recovery models The compound interacts with growth hormone receptors, the FAK-paxillin pathway, and vascular endothelial growth factor (VEGF) signaling
A body that burns fat for fuel rather than defaulting to sugar
Alvarez, B., Comini, M
Hinrichs A, Kessler B, Kurome M, Blutke A, Kemter E, Bernau M, Scholz AM, Rathkolb B, Renner S, Bultmann S, Leonhardt H, de Angelis MH, Nagashima H, Hoeflich A, Blum WF, Bidlingmaier M, Wanke R, Dahlhoff M, Wolf E
In controlled trials, GHK-Cu treatment resulted in faster wound closure, reduced inflammation, and improved tissue quality compared to standard care [1]
Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels